ADM and cancer: Different with CPT, which targets TOPO1 and induces DNA damage in cancer [28,35,36] by increasing cellular ROS [37-39], ADM targets TOPO2 and its cytotoxicity towards cancer cells does not originate from oxidative stress, as demonstrated by the fact that antioxidant treatment can not decrease ADM-induced apoptosis in cancer cells [40].